Bioeconomy Capital
Facts
Is this your organization? Claim it
Arzeda Raises $33M Series B Led by Conti Ventures to Commercialize Computer-Designed Enzymes
Arzeda raised $33 million in a Series B led by Conti Ventures with participation from Lewis & Clark Agrifood, Bunge Ventures, Circulate Capital, and returning investors to accelerate commercialization of computer-designed enzymes for food, home care, chemicals, and other sectors.
Parse Biosciences raises $41.5M to scale Evercode single-cell RNA sequencing kits that profile up to 1M cells
Parse Biosciences, a Seattle startup co-founded by CEO Alex Rosenberg and CTO Charles Roco, raised $41.5 million to expand its single-cell RNA sequencing kits and software, which scale to profile up to one million cells using standard lab equipment. The company, launched from University of Washington research, now has more than 300 customers and emphasizes ease of use versus competitors requiring specialized hardware.
Parse Biosciences raises $7M led by Bioeconomy Capital to scale single-cell RNA-seq tech; total funding $9M
Parse Biosciences (formerly Split Biosciences) raised $7 million to grow its single-cell RNA-seq 'Whole Transcriptome Kit' that profiles up to 100,000 cells across 48 samples; the 16-person startup spun out of UW in 2018 and has 40+ labs using its kit.
